Risk stratification of resistant hypertension in chronic kidney disease

Journal of the American College of Cardiology

Volumn 61, Issue 24, 2013, Pages 2468-2470

  Weinrauch, Larry A ^a,b   Desai, Akshay S ^b   Skali, Hicham ^b   D'Elia, John A ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ambulatory blood pressure monitoring; chronic kidney disease; resistant hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DISEASE CLASSIFICATION; EVIDENCE BASED MEDICINE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; KIDNEY DENERVATION; NOTE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RESISTANT HYPERTENSION; RISK ASSESSMENT;

EID: 84878938104     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.03.048     Document Type: Editorial

References (19)

1. J. Coresh, G.L. Wei, and G. McQuillan Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 161 2001 1207 1216
2. M.G. Saelen, L.K. Prøsch, and H. Gudmundsdottir Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function Blood Press 14 2005 170 176
3. L. De Nicola, F.B. Gabbai, and R. Agarwal Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients J Am Coll Cardiol 61 2013 2461 2467
4. G. Bakris, J. Vassalotti, E. Ritz CKD Consensus Working Group National Kidney Foundation consensus conference on cardiovascular and kidney disease and diabetes risk: an integrated therapeutic approach to reduce events Kidney Int 78 2010 726 736
5. N.A. Khan, B. Hemmelgarn, R. Padwal Canadian Hypertension Education Program The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy Can J Cardiol 23 2007 539 550
6. D.A. Calhoun, D. Jones, and S. Textor Resistant hypertension: diagnosis evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council of for High Blood Pressure Research Hypertension 51 2008 1403 1419
7. L.A. Weinrauch, J.A. D′Elia, and R.E. Gleason Hypertensive control in hemodialysis units Am J Hypertens 15 2002 135A
8. J.A. D'Elia, B. Roshan, M. Maski, and L.A. Weinrauch Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney Int J Nephrol Renovasc Dis 2 2009 39 49
9. H.H. Parving, B.M. Brenner, J.J. McMurray ALTITUDE Investigators Cardiorenal end points in a trial of aliskiren for type 2 diabetes N Engl J Med 367 2012 2204 2213
10. J.F. Mann, C. Anderson, P. Gao on behalf of the ONTARGET Investigators Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcome: results of the ONTARGET trial J Hypertens 31 2013 414 421
11. Symplicity HTN-1 Investigators Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months Hypertension 57 2011 911 917
12. M.D. Esler, H. Krum, M. Schlaich, R.E. Schmieder, M. Böhm, P.A. Sobotka Symplicity HTN-2 Investigators Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized controlled trial Circulation 126 2012 2976 2982
13. L.A. Weinrauch, and J.A. D'Elia Renal artery stenosis: "fortuitous diagnosis", problematic therapy J Am Coll Cardiol 43 2004 1614 1616
14. ASTRAL Investigators K. Wheatley, and N. Ives Revascularization versus medical therapy for renal-artery stenosis N Engl J Med 361 2009 1953 1962
15. ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine (US). Renal Denervation and Hypertension: Open Studies. Available at: http://clinicaltrials.gov/ct2/results?term= Renal+Denervation+and+Hypertension%3A+Open+Studies. Accessed May 8, 2013.
16. S. Laurent, M. Schlaick, and M. Esler New drugs, procedures, devices for hypertension Lancet 380 2012 591 600
17. M.R. Hänninen, T.J. Niiranen, P.J. Puukka, J. Johansson, and A.M. Jula Prognostic significance of masked and white coat hypertension in the general population: the Finn-Home study J Hypertension 30 2012 705 712
18. J.M. Boivin, T.J. Tsou-Gaillet, R. Fay, D. Dobre, P. Rossignol, and F. Zannad Influence of the recommendations on the implementation of home blood pressure measurements by French general practitioners: a 2004-2009 longitudinal survey J Hypertension 29 2011 2105 2115
19. R.J. McManus, J. Mant, and E.P. Bray Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomized controlled trial Lancet 376 2010 163 172